Hyog Young Kwon

5.1k total citations · 3 hit papers
43 papers, 3.7k citations indexed

About

Hyog Young Kwon is a scholar working on Molecular Biology, Hematology and Cancer Research. According to data from OpenAlex, Hyog Young Kwon has authored 43 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Molecular Biology, 9 papers in Hematology and 8 papers in Cancer Research. Recurrent topics in Hyog Young Kwon's work include Cancer-related molecular mechanisms research (6 papers), Epigenetics and DNA Methylation (6 papers) and Chronic Myeloid Leukemia Treatments (6 papers). Hyog Young Kwon is often cited by papers focused on Cancer-related molecular mechanisms research (6 papers), Epigenetics and DNA Methylation (6 papers) and Chronic Myeloid Leukemia Treatments (6 papers). Hyog Young Kwon collaborates with scholars based in South Korea, United States and Singapore. Hyog Young Kwon's co-authors include Ita Novita Sari, Yun Kyung Lee, Tannishtha Reya, Jordan Blum, Lan Thi Phi, Nayoung Jun, Kwang Seock Kim, Sanghyun Lee, Yinggui Yang and Alan Chen and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Nature Communications.

In The Last Decade

Hyog Young Kwon

41 papers receiving 3.7k citations

Hit Papers

Cancer Stem Cells (CSCs) in Drug Resista... 2009 2026 2014 2020 2018 2009 2023 200 400 600

Peers

Hyog Young Kwon
Peter P. Ruvolo United States
Yue Huang China
Mario P. Tschan Switzerland
Joan Gil Spain
Jin Hyen Baek United States
Hyog Young Kwon
Citations per year, relative to Hyog Young Kwon Hyog Young Kwon (= 1×) peers Jörg Bäsecke

Countries citing papers authored by Hyog Young Kwon

Since Specialization
Citations

This map shows the geographic impact of Hyog Young Kwon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hyog Young Kwon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hyog Young Kwon more than expected).

Fields of papers citing papers by Hyog Young Kwon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hyog Young Kwon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hyog Young Kwon. The network helps show where Hyog Young Kwon may publish in the future.

Co-authorship network of co-authors of Hyog Young Kwon

This figure shows the co-authorship network connecting the top 25 collaborators of Hyog Young Kwon. A scholar is included among the top collaborators of Hyog Young Kwon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hyog Young Kwon. Hyog Young Kwon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jun, Nayoung, et al.. (2025). Regulation of metabolic adaptation and leukemia progression by MUSASHI2-DEPTOR-KIF11 axis. Leukemia. 39(12). 2935–2945.
3.
Sari, Ita Novita, et al.. (2023). Cancer cachexia: molecular mechanisms and treatment strategies. Journal of Hematology & Oncology. 16(1). 54–54. 112 indexed citations breakdown →
4.
Sari, Ita Novita, et al.. (2021). Metabolism and function of polyamines in cancer progression. Cancer Letters. 519. 91–104. 103 indexed citations
5.
Wijaya, Yoseph Toni, et al.. (2021). Amelioration of muscle wasting by gintonin in cancer cachexia. Neoplasia. 23(12). 1307–1317. 11 indexed citations
6.
Sari, Ita Novita, Yinggui Yang, Yoseph Toni Wijaya, et al.. (2020). AMD1 is required for the maintenance of leukemic stem cells and promotes chronic myeloid leukemic growth. Oncogene. 40(3). 603–617. 11 indexed citations
7.
Phi, Lan Thi, Yoseph Toni Wijaya, Ita Novita Sari, et al.. (2019). <p>20(R)-Ginsenoside Rg3 Influences Cancer Stem Cell Properties and the Epithelial-Mesenchymal Transition in Colorectal Cancer via the SNAIL Signaling Axis</p>. OncoTargets and Therapy. Volume 12. 10885–10895. 22 indexed citations
8.
Kim, Kwang Seock, Dongjun Jeong, Ita Novita Sari, et al.. (2019). miR551b Regulates Colorectal Cancer Progression by Targeting the ZEB1 Signaling Axis. Cancers. 11(5). 735–735. 3 indexed citations
9.
Sittipo, Panida, et al.. (2018). Toll-Like Receptor 2-Mediated Suppression of Colorectal Cancer Pathogenesis by Polysaccharide A From Bacteroides fragilis. Frontiers in Microbiology. 9. 1588–1588. 41 indexed citations
10.
Kwon, Hyog Young, et al.. (2018). MicroRNA, an Antisense RNA, in Sensing Myeloid Malignancies. Frontiers in Oncology. 7. 331–331. 4 indexed citations
11.
Jeong, Dongjun, Seunghyun Oh, Doyeon Kim, et al.. (2017). Karyopherin α-2 is a reliable marker for identification of patients with high-risk stage II colorectal cancer. Journal of Cancer Research and Clinical Oncology. 143(12). 2493–2503. 15 indexed citations
12.
Yang, Yinggui, et al.. (2016). Tetraspanins: Spanning from solid tumors to hematologic malignancies. Experimental Hematology. 44(5). 322–328. 34 indexed citations
13.
Koh, Young Wha, et al.. (2016). Q787Q EGFR Polymorphism as a Prognostic Factor for Lung Squamous Cell Carcinoma. Oncology. 90(5). 289–298. 10 indexed citations
14.
Jeong, Dongjun, Hyungjoo Kim, Seunghyun Oh, et al.. (2016). Abstract 709: In vitro functional study of novel oncogene serine protease 33 (PRSS33) and the clinical significance of PRSS33 expression in colorectal cancer patients. Cancer Research. 76(14_Supplement). 709–709. 1 indexed citations
15.
Jeong, Dongjun, Hyungjoo Kim, Chang‐Jin Kim, et al.. (2015). RhoA is associated with invasion and poor prognosis in colorectal cancer. International Journal of Oncology. 48(2). 714–722. 35 indexed citations
16.
Zimdahl, Bryan, Takahiro Ito, Jeevisha Bajaj, et al.. (2014). Lis1 regulates asymmetric division in hematopoietic stem cells and in leukemia. Nature Genetics. 46(3). 245–252. 81 indexed citations
17.
Ito, Takahiro, Hyog Young Kwon, Bryan Zimdahl, et al.. (2010). Regulation of myeloid leukaemia by the cell-fate determinant Musashi. Nature. 466(7307). 765–768. 272 indexed citations
18.
Zhao, Chen, Jordan Blum, Alan Chen, et al.. (2007). Loss of β-Catenin Impairs the Renewal of Normal and CML Stem Cells In Vivo. Cancer Cell. 12(6). 528–541. 480 indexed citations
19.
Wu, Mingfu, Hyog Young Kwon, Jordan Blum, et al.. (2007). Imaging Hematopoietic Precursor Division in Real Time. Cell stem cell. 1(5). 541–554. 209 indexed citations
20.
Kim, Dae Keun, et al.. (1998). Isolation of a multidrug resistance inhibitor fromAconitum pseudo-laeve var.erectum. Archives of Pharmacal Research. 21(3). 344–347. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026